Patent: How Pfizer, Bristol Myers Squibb, and Johnson & Johnson Are Addressing Patent 2024 Expirations
Patent: How Pfizer, Bristol Myers Squibb, and Johnson & Johnson Are Addressing Patent 2024 Expirations Patent: The pharmaceutical industry is…
Regulatory Pharma Blogs
Patent: How Pfizer, Bristol Myers Squibb, and Johnson & Johnson Are Addressing Patent 2024 Expirations Patent: The pharmaceutical industry is…
5 Key FDA Decisions to Keep an Eye on in the Latter Half of 2024 5 Key FDA Decisions :This…
Dr. Yusuf Hamied: How an Indian Entrepreneur Challenged Big Pharma to Offer AIDS Medications at $1 a Day Dr. Yusuf…
Regulatory affairs in clinical research are vital, ensuring trials comply with rules for patient safety and effective treatments. Introduction to…
Sarepta Gains Complete Approval and Expanded Label for DMD Gene Therapy Sarepta The FDA announced on Thursday that Sarepta Therapeutics’…
Spikevax Modernas latest COVID vaccine outperforms the current shot in a crucial efficacy trial involving adults. Spikevax Moderna latest COVID…
Clarios SpiroSphere® with wireless ECG- FDA clears, simplifying clinical trial data collection. Clarios SpiroSphere The FDA has granted 510(k) clearance…
DSCSA (Drug Supply Chain Security Act): FDA extends on 24 DSCSA tracking rules for small dispensers by two years and…
Medical device equipment: The report suggests strategies to enhance accessibility and cost-effectiveness of crucial medical device equipment. Medical device equipment…
GAMP 5: Concept of GAMP 5 in Pharmaceuticals GAMP-5 Good Automated Manufacturing Practice consists of guidelines aimed at both users…